Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|122|19|2941-2951

ISSN： 0008-543x

Source： CANCER, Vol.122, Iss.19, 2016-10, pp. : 2941-2951

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia

By  

PEDIATRICS INTERNATIONAL, Vol. 60, Iss. 1, 2018-01 ,pp. : 85-87

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pre-Emptive Treatment with Nilotinib after Second Allogeneic Transplantation in a Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patient with High Risk of Relapse

By  

Acta Haematologica, Vol. 123, Iss. 4, 2010-05 ,pp. : 242-247

Karger

Access to resources Recommend Favorite

Impact of postremission consolidation chemotherapy on outcome after reduced‐intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: A report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

By  

CANCER, Vol. 120, Iss. 6, 2014-03 ,pp. : 855-863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome‐positive acute lymphoblastic leukemia

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1514-1519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 148-152

John Wiley & Sons Inc

Access to resources Recommend Favorite